Rating History for Karyopharm Therapeutics (KPTI) by Baird

More Stocks Rated by Baird | Latest Ratings for KPTI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/31/2026 Colleen Kusy Downgrade Neutral
(Outperform)		 3.00
(15.00)		 6.86
(1.62)		 -76.38% Details